Apontis Pharma AG Company Description

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes.

The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Apontis Pharma AG

Country	Germany
Founded	1946
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	137
CEO	Bruno Wohlschlegel

Contact Details

Address: Alfred-Nobel-Str. 10 Monheim am Rhein, 40789 Germany
Phone	49 2173 8955 4949
Website	apontis-pharma.de

Stock Details

Ticker Symbol	APPH
Exchange	Deutsche Börse Xetra
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	DE000A3CMGM5
SIC Code	2834

Key Executives

Name	Position
Bruno Wohlschlegel	Chief Executive Officer and Chairman of Management Board
Thomas Milz	Chief Product Officer and Deputy Chairman of Management Board
Thomas Zimmermann	Chief Financial Officer and Member of Management Board
Harald Weyand	Head of Marketing
Susanne Böhm	Head of Human Resources
Dr. Olaf Randerath	Head of Medicine
Dr. Susanne Endreß	Head of QA, Drug Safety and Regulatory Affairs